For the Inventor, By the Inventor

Enter assignee name

Durham, NC, United States of America

Nobex Corporation

USPTO Granted Patents = 40

CIPO Patents = 1

Forward Citations = 779

Loading Chart...

Loading Chart...

26 inventors (with patents filed for the assignee):

Nnochiri Ekwuribe (40 out of 72 patents)

Christopher H Price (18 out of 21 patents)

Aslam M Ansari (12 out of 15 patents)

4. Amy L Odenbaugh (9 out of 15 patents)

5. Jennifer A Riggs-Sauthier (5 out of 98 patents)

6. Balasingam Radhakrishnan (4 out of 37 patents)

7. Jennifer Riggs (4 out of 12 patents)

8. Richard Soltero (4 out of 13 patents)

9. Anthony James Hickey (3 out of 23 patents)

10. Tatyana Dyakonov (3 out of 34 patents)

11. Li Li Bovet (3 out of 5 patents)

12. Bruce Rehlaender (3 out of 4 patents)

13. Balasingam Rhadakrishnan (3 out of 3 patents)

14. Kenneth Duke James, Jr (2 out of 11 patents)

15. Foyeke Opawale (2 out of 3 patents)

Core Competencies:

Immunoregulatory Compounds

Polyethylene Glycol

Amphiphilic Prodrugs

Drug-Oligomer Conjugates

Insulin Polypeptide Conjugates

Blood-Brain Barrier Delivery

Pharmaceutical Compositions

Enantiomer Synthesis

Gastrointestinal Inflammatory Treatments

Growth Hormone Conjugates

Taxane Prodrugs

Acyanilides Synthesis

40 patents: Sort by Forward Citations

1. 7151095 - Immunoregulatory compounds and derivatives and methods of treating diseases therewith (2006-12-19),

2. 7119162 - Substantially monodispersed mixtures of polymers having polyethylene glycol moieties (2006-10-10),

3. 7119074 - Treatment of cancers, tumors and malignancies using amphiphilic prodrugs (2006-10-10),

4. 7084121 - Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same (2006-08-01),

5. 7084114 - Mixtures of insulin drug-oligomer comprising polyalkylene glycol (2006-08-01),

6. 7060675 - Methods of treating diabetes mellitus (2006-06-13),

7. 7030084 - Drug-oligomer conjugates with polyethylene glycol components (2006-04-18),

8. 7030082 - Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith (2006-04-18),

9. 7022869 - Methods of asymmetrically synthesizing enantiomers of casodex, its derivatives and intermediates thereof (2006-04-04),

10. 6956051 - Enkephalin conjugates (2005-10-18),

11. 6943148 - Methods for delivering therapeutics across blood-barrier and for altering receptor binding affinity (2005-09-13),

12. 6930090 - Methods of activating a receptor using amphiphilic drug-oligomer conjugates (2005-08-16),

13. 6913903 - Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same (2005-07-05),

14. 6903082 - Methods of treating inflammatory conditions of the gastrointestinal tract using 4-APAA and compositions thereof (2005-06-07),

15. 6867183 - Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith (2005-03-15),

Nobex Corporation is a leading technology company specializing in mobile application development and software solutions. With a diverse portfolio of innovative products, we aim to revolutionize the way people interact with mobile devices. Our team of skilled professionals is dedicated to delivering top-notch mobile experiences and creating cutting-edge solutions for various industries. Visit our website to discover how Nobex Corp can enhance your mobile presence and drive your business forward.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

40 Patents

#24 in Durham, NC

#190 in North Carolina

#8,348 in US

#16,567 in the World

Durham, NC, United States of America

Nobex Corporation

Forward Citations = 779

26 inventors:

Nnochiri Ekwuribe (40 out of 72 patents)

Christopher H Price (18 out of 21 patents)

Aslam M Ansari (12 out of 15 patents)

4. Amy L Odenbaugh (9 out of 15 patents)

5. Jennifer A Riggs-Sauthier (5 out of 98 patents)

Please report any incorrect information to support@idiyas.com

Loading…